US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Antisense & RNAi Technology: research reports

Find comprehensive market research and company reports on the AntiSense & RNAi Technology Industry. More specifically, find reports on the Cancer Therapies, Bioinformatics and Bioprocessing markets. Reports include data on market segmentation, size and growth in US, UK, Europe, Asia and global markets.
RSS Feeds

Antisense & RNAi Technology market research reports and industry analysis

< prev 1    3  4  
RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update 2014
3/25/2014 | published by: BioSeeker Group AB
... molecules or protein-based therapies. There are today 56 companies plus partners developing 96 RNA (miRNA, RNAi & siRNA) drugs in 129 developmental projects in cancer. In addition, the accumulated number of ceased drugs over the ...  |  read more...
$3,747.50
RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer 2014
3/25/2014 | published by: BioSeeker Group AB
... drugs known to affect more than 157 specific intracellular signaling pathways for the treatment of more than 25 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding ...  |  read more...
$1,872.50
RNAi for Therapeutic Applications: Technology and Market 2014-2024
2/12/2014 | published by: Visiongain
... new sales predictions and explore developments. You unlock that emerging medical industry. And you assess its results, trends, technologies, potentials, and opportunities. Visiongain's new report forecasts those revenues to 2024 at overall world market, product, ...  |  read more...
$2,788.00
Antisense Therapeutics Limited - Product Pipeline Review - 2014
1/31/2014 | published by: Global Markets Direct
... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ...  |  read more...
$1,500.00
Global RNAi Drug Delivery Market 2014-2018
1/17/2014 | published by: Infiniti Research Limited - TechNavio
... this market growth is the increase in RNA therapeutic development. The Global RNAi Drug Delivery market has also been witnessing some key technological advancements. However, the targeted delivery of RNA molecules is expected to pose ...  |  read more...
$2,000.00
Global miRNA Market Outlook to 2018
12/1/2013 | published by: RNCOS
... are numerous clinical trials being organized all over the world in order to assess the potential of miRNA in diverse fields such as Cancer, Asthma, Heart disorders, Diabetes, Hepatitis etc. The report, “Global miRNA Market ...  |  read more...
$1,200.00
2013 Biotechnology Research Review
12/1/2013 | published by: BCC Research
... and $290 million by 2018, with a compound annual growth rate (CAGR) of 5.7% for the period of 2013 to 2018. The next generation sequencing market reached $231.7 million in 2012. The market is expected ...  |  read more...
$950.00
RNAi Technologies and Global Markets
10/1/2013 | published by: BCC Research
... with data from 2011 and 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) for the period 2013 to 2018. A breakdown of the technologies: RNAi for drug delivery (by nanoparticle delivery, ...  |  read more...
$6,650.00
Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to 2018
7/5/2013 | published by: MarketsandMarkets
... market is valued at $287 million in 2013 and is expected to reach $2.1 billion by 2018. Aptamers existed in parallel with antibodies for two decades, but its market potential was not utilized, even to ...  |  read more...
$4,650.00
Conference Documentation: RNA Therapeutics
6/5/2013 | published by: SMI Publishing, Ltd
... the key to the eradication of a number of diseases. SMi’s 2013 RNA Therapeutics conference will look to discuss and share some of the latest findings and research in the field of RNAi technologies and ...  |  read more...
$788.78
Epigenetic Therapies and Technologies: World Market Prospects 2013-2023
1/9/2013 | published by: Visiongain
... for those therapies, technologies and diagnostic products. There you find sales data, R&D trends, opportunities and commercial prospects. That analysis lets you assess forecasted sales at overall world market, submarket, product, regional and national level. ...  |  read more...
$2,401.00
2012 Oncology Market Research Review
12/1/2012 | published by: BCC Research
... and markets by therapeutic area. Implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and by the most important ...  |  read more...
$950.00
RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update 2012
10/16/2012 | published by: BioSeeker Group AB
... RNA (miRNA, RNAi & siRNA) drugs in 95 developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 25 drugs. Rna (Mirna, Rnai & Sirna) Therapy ...  |  read more...
$2,249.00
Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets
10/1/2012 | published by: BCC Research
... trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017 Identification of emerging technology growth opportunities in aptamer use as adjuvants for siRNA delivery, vaccines, and antisense ...  |  read more...
$6,650.00
Strategies and Technologies for Target Validation
9/28/2012 | published by: Datamonitor
... major cause of clinical-stage attrition. This report analyses the strategic and technological developments in the field. Features and benefits Understand how the differences between phenotypic and target-based approaches to drug discovery influence target validation strategies. ...  |  read more...
$3,800.00
Analysis of Nucleic Acid Testing Instrumentation And Strategic Profiles of Leading Suppliers
9/27/2012 | published by: Venture Planning Group
... on the market, e.g., DNA extractors, DNA synthesizers, thermal cyclers, robotic work-stations, and automated DNA probe analysis systems. The report reviews current instrumentation technologies, and compares features of leading molecular diagnostics analyzers marketed by Abbott, ...  |  read more...
$3,500.00
Analysis of Nucleic Acid Testing Technologies And Strategic Profiles of Leading Suppliers
9/27/2012 | published by: Venture Planning Group
... presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Contains 180 pages Please ...  |  read more...
$3,500.00
Analysis of Emerging Nucleic Acid Testing Assays And Strategic Profiles of Leading Suppliers
9/21/2012 | published by: Venture Planning Group
... report also presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 549 ...  |  read more...
$3,500.00
Analysis of the World Nucleic Acid Testing Market Sales Forecasts by Country and Strategic Profiles of Leading Suppliers
9/12/2012 | published by: Venture Planning Group
... also presents strategic profiles of current and emerging suppliers of nucleic acid testing products in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains ...  |  read more...
$3,500.00
Future Horizons in the Italian Nucleic Acid Testing Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Market Segment
8/28/2012 | published by: Venture Planning Group
... impact during the next ten years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year test volume and reagent sales forecasts for the ...  |  read more...
$5,900.00
Future Horizons in the Spanish Nucleic Acid Testing Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Market Segment
8/28/2012 | published by: Venture Planning Group
... impact during the next ten years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year test volume and reagent sales forecasts for the ...  |  read more...
$5,900.00
Future Horizons in the UK Nucleic Acid Testing Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Market Segment
8/28/2012 | published by: Venture Planning Group
... impact during the next ten years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year test volume and reagent sales forecasts for the ...  |  read more...
$5,900.00
Future Horizons in the US Nucleic Acid Testing Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Market Segment
8/28/2012 | published by: Venture Planning Group
... impact during the next ten years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year test volume and reagent sales forecasts for the ...  |  read more...
$8,400.00
Future Horizons in the French Nucleic Acid Testing Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Market Segment
8/28/2012 | published by: Venture Planning Group
... impact during the next ten years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year test volume and reagent sales forecasts for the ...  |  read more...
$5,900.00
Future Horizons in the German Nucleic Acid Testing Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Market Segment
8/28/2012 | published by: Venture Planning Group
... impact during the next ten years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year test volume and reagent sales forecasts for the ...  |  read more...
$5,900.00
< prev 1    3  4  
 
Our Clients